aminocaproic acid has been researched along with Infantile Respiratory Distress Syndrome in 1 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horwitz, JR | 1 |
| Cofer, BR | 1 |
| Warner, BW | 1 |
| Cheu, HW | 1 |
| Lally, KP | 1 |
1 trial available for aminocaproic acid and Infantile Respiratory Distress Syndrome
| Article | Year |
|---|---|
A multicenter trial of 6-aminocaproic acid (Amicar) in the prevention of bleeding in infants on ECMO.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Cerebral Hemorrhage; Double-Blind Method; Extracorporeal | 1998 |